We Want to Do Our Part: A Corporate Funder Steps up for Trans Communities

We Want to Do Our Part: A Corporate Funder Steps up for Trans Communities

Transgender communities face inordinate challenges, but receive a small slice of philanthropic funding. With a new grantmaking program that draws on input from the trans community, Gilead Sciences is helping to change that.

Read More

The Corporate Funder Giving New Attention to HIV/AIDS in the American South

The Corporate Funder Giving New Attention to HIV/AIDS in the American South

Gilead Sciences recently announced a 10-year, $100 million commitment to combat HIV/AIDS in the South—the latest funder to respond to a disturbingly high prevalence of infections in the region. 

Read More